Curevac, Armed With Covid-19 Vaccine Deal, Plots 'Pandemic-Scale' Euro Manufacturing Expansion

CureVac, armed with COVID-19 vaccine deal, plots 'pandemic-scale' Euro manufacturing expansion

EU Debates | eudebates.tv

Commission complete contract with CureVac. 405 million doses of a coronavirus vaccine are purchased

EU Debates | eudebates.tv

Enough Pharma Capacity to Vaccinate World by End of 2021: CureVac CEO

Bloomberg Television

CureVac CEO on IPO Pricing, Covid-19 Vaccine, Partners

Bloomberg Television

mRNA will play a part in pandemic preparedness for the future, CureVac CEO says

CNBC International News

CureVac's COVID-19 vaccine suitable for standard refrigeration

European Commission strikes deal with German biotech firm CureVac for potential COVID-19 vaccine

EU debates with AstraZeneca, Moderna, CureVac and Novavax to increase COVID-19 vaccine production

EU Debates | eudebates.tv

CureVac working on a second generation vaccine to combat Covid variants, CEO says

CNBC International News

How to invest in mRNA vaccines that could revolutionise medicine | Counting the Cost

Al Jazeera English

Why is Germany's CureVac vaccine just 48% effective? | Covid-19 Special

CureVac to Release Results of Covid Vaccine Trials

Bloomberg Television

Coronavirus vaccines: CureVac jumps 200% in public debut, plus UK signs deals with J&J and Novavax

CureVac withdraws mRNA Covid vaccine application in Europe

CNBC Television

Enough Pharma Capacity to Vaccinate World by End of 2021: CureVac CEO

Bloomberg Quicktake

Covid-19 roundup: EU begins reviewing Moderna vaccine; CureVac and EU agree to 405M-dose deal

EU Debates | eudebates.tv

COVID-19: GlaxoSmithKline, CureVac to develop vaccine against coronavirus variants

CNA

CureVac Will Make the Next-Gen Covid Shot

Bloomberg Television

EU and CureVac join forces in search for a coronavirus vaccine

EU Science & Innovation

CureVac CEO on the company's IPO and Covid-19 vaccine research

CNBC Television